Drug-Resistant Fungus Candida auris Spreads to 23 States in 2026
The drug-resistant fungus Candida auris has been confirmed in 23 states in 2026, continuing its spread despite containment efforts, according to new CDC data.
Tampa St. Petersburg, FL, August 2, 2026 —
The Centers for Disease Control and Prevention (CDC) has reported that the drug-resistant fungus Candida auris has been confirmed in 23 states as of 2026. This marks a continued expansion of the pathogen’s presence across the United States, occurring despite ongoing containment initiatives.
Candida auris is an infectious fungus that can cause serious health issues, particularly in healthcare settings. It has gained attention due to its ability to resist common antifungal medications, making infections difficult to treat. The fungus can spread through direct contact with infected individuals or contaminated environmental surfaces.
The CDC data indicates that the number of states reporting confirmed cases of Candida auris has risen. While efforts are being made to contain its spread, the pathogen’s persistent growth highlights the challenges in controlling drug-resistant infections.
Further details regarding specific containment strategies and the precise number of cases within these 23 states were not immediately available. The CDC continues to monitor the situation and provide guidance to healthcare facilities to prevent and manage Candida auris infections.
Story summarized from the original created by Alix Martichoux and The Hill on www.wfla.com, see more information here.
